Sign In
Buy GDRX
$2.67
+0.100 (+3.89%)
At Close: Jun 23, 2026
GoodRx Holdings, Inc. (GDRX) Q2 2022 Earnings Call Transcript
01:30am, Tuesday, 09'th Aug 2022 The Motley Fool
GDRX earnings call for the period ending June 30, 2022.
GoodRx Holdings, Inc. (GDRX) Q2 Earnings and Revenues Beat Estimates
10:55pm, Monday, 08'th Aug 2022 Zacks Investment Research
GoodRx Holdings, Inc. (GDRX) delivered earnings and revenue surprises of 50% and 4.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
GoodRx Closes Books on Downbeat Q2 With Win as Grocery Dispute Ends
10:50pm, Monday, 08'th Aug 2022
No feel-good prescription can put a happy face on GoodRx's downcast second-quarter performance, despite news that its issue with a major grocery pharmacy chain is resolved. Revenue for the quarter gre
GoodRx Holdings, Inc. (GDRX) Q2 Earnings and Revenues Beat Estimates
08:20pm, Monday, 08'th Aug 2022
GoodRx Holdings, Inc. (GDRX) delivered earnings and revenue surprises of 50% and 4.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
GoodRx stock rockets after earnings as company says snag with large grocer has been resolved
04:56pm, Monday, 08'th Aug 2022
Shares of GoodRx Holdings Inc. were popping more than 30% in after-hours trading Monday after the company, which offers services for people looking to compare prescription drug prices, topped expectat
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session
04:49pm, Monday, 08'th Aug 2022 Benzinga
Gainers
Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates
11:45pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Natera (NTRA) delivered earnings and revenue surprises of -2.04% and 2.11%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Sera Prognostics, Inc. (SERA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
02:00pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Sera Prognostics, Inc. (SERA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: GoodRx Holdings, Inc. (GDRX) Q2 Earnings Expected to Decline
02:01pm, Monday, 01'st Aug 2022 Zacks Investment Research
GoodRx Holdings, Inc. (GDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
McKesson (MCK) to Report Q1 Earnings: What's in the Cards?
04:12pm, Friday, 29'th Jul 2022 Zacks Investment Research
McKesson's (MCK) fiscal first-quarter results are likely to reflect the solid show by the U.S. Pharmaceutical and Specialty Solutions segment.
What's in the Offing for QuidelOrtho (QDEL) in Q2 Earnings?
12:57pm, Friday, 29'th Jul 2022 Zacks Investment Research
QuidelOrtho's (QDEL) second-quarter results are likely to reflect strength across both its COVID and non-COVID businesses.
AMN Healthcare (AMN) to Post Q2 Earnings: What's in the Cards?
05:34pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
AMN Healthcare's (AMN) second-quarter results are likely to reflect solid demand across all its segments.
NextGen Healthcare (NXGN) Beats on Q1 Earnings, Cuts FY23 View
05:21pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
NextGen Healthcare's (NXGN) first-quarter fiscal 2023 results reflect strength in its Recurring revenues.
Neogen (NEOG) Q4 Earnings Top Estimates, Gross Margin Up
03:54pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Neogen (NEOG) delivers better-than-expected results for the fiscal fourth quarter, with robust segmental performance driving the top line.
ELV vs. GDRX: Which Stock Should Value Investors Buy Now?
03:40pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
ELV vs. GDRX: Which Stock Is the Better Value Option?
